
Weight Loss
Semaglutide
Semaglutide is a once-weekly injectable dual glucagon-like peptide 1 (GLP-1) receptor and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. It works by increasing insulin production and lowering glucagon secretion as well as targeting areas in the brain that regulate appetite and food intake. A small change in the molecule allows the drug to last weeks in our bodies rather than the natural version our bodies make, which lasts minutes.
Semaglutide has been shown to act in the following ways:
- Delays how quickly our stomachs digest food, leading to a feeling of fullness and satisfaction with smaller meal sizes.
- Slows intestinal motility so you will feel fuller longer after meals.
- Lowers blood sugars, in part by reducing the production of sugar in the liver.
- Stimulates insulin secretion by the pancreas.
- Decreases inflammation throughout the body, which leads to adiponectin release and fat lipolysis
Tirzepatide
Tirzepatide is a once-weekly injectable dual glucagon-like peptide 1 (GLP-1) receptor and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. It works by increasing insulin production and lowering glucagon secretion as well as targeting areas in the brain that regulate appetite and food intake. A small change in the molecule allows the drug to last weeks in our bodies rather than the natural version our bodies make, which lasts minutes.
Tirzepatide works in the following ways:
- Delays how quickly the stomach digests food, leading to a feeling of fullness and satisfaction with smaller meal sizes.
- Slows intestinal motility so you will feel fuller longer after meals.
- Dual action receptors allow for lower blood sugars, in part by reducing the production of sugar in the liver.
- Stimulates insulin secretion by the pancreas.
- GIP increases energy expenditure, resulting in weight loss.

